147 related articles for article (PubMed ID: 2415436)
1. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
[TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
[TBL] [Abstract][Full Text] [Related]
5. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
[TBL] [Abstract][Full Text] [Related]
6. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV
J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC
Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
[TBL] [Abstract][Full Text] [Related]
10. Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B.
Buti M; Rodriguez-Frias F; Genesca J; Arranz A; Jardi R; Esteban R; Guardia J
Liver; 1993 Jun; 13(3):136-40. PubMed ID: 7687734
[TBL] [Abstract][Full Text] [Related]
11. Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.
Guardia J; Esteban R; Buti M; Jardí R; Allende H; Esteban JI
Liver; 1986 Apr; 6(2):118-22. PubMed ID: 2426552
[TBL] [Abstract][Full Text] [Related]
12. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
[TBL] [Abstract][Full Text] [Related]
13. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
[TBL] [Abstract][Full Text] [Related]
14. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
Brook MG; Petrovic L; McDonald JA; Scheuer PJ; Thomas HC
J Hepatol; 1989 Mar; 8(2):218-25. PubMed ID: 2469711
[TBL] [Abstract][Full Text] [Related]
15. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
Novick DM; Lok AS; Thomas HC
J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
[TBL] [Abstract][Full Text] [Related]
16. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
[TBL] [Abstract][Full Text] [Related]
17. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
Perrillo RP
J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577
[TBL] [Abstract][Full Text] [Related]
18. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
Hoofnagle JH
J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
[TBL] [Abstract][Full Text] [Related]
19. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]